Lyfnua
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lyfnua, covering 2025-12-08 to 2025-12-08. Get the full timeline:
Most recent: EMA Authorised: Lyfnua (gefapixant) — Merck Sharp & Dohme B.V.
1 regulatory and trial event tracked for Lyfnua, covering 2025-12-08 to 2025-12-08. Get the full timeline:
Most recent: EMA Authorised: Lyfnua (gefapixant) — Merck Sharp & Dohme B.V.